Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA1 | P00915 | 3/20 | 0.55 |
| ▸ | CA2 | P00918 | 3/20 | 0.55 |
| ▸ | CA7 | P43166 | 2/20 | 0.55 |
| ▸ | CA9 | Q16790 | 2/20 | 0.55 |
| ▸ | CA12 | O43570 | 1/20 | 0.55 |
| ▸ | CA4 | P22748 | 1/20 | 0.55 |
| ▸ | CA14 | Q9ULX7 | 1/20 | 0.55 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.44 |
| ▸ | TP53 | P04637 | 2/20 | 0.44 |
| ▸ | TSHR | P16473 | 1/20 | 0.44 |
| ▸ | ADRA2B | P18089 | 1/20 | 0.44 |
| ▸ | PTGS1 | P23219 | 1/20 | 0.44 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.44 |
| ▸ | MAPK1 | P28482 | 2/20 | 0.43 |
| ▸ | HTT | P42858 | 1/20 | 0.43 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.43 |
| ▸ | GRM5 | P41594 | 1/20 | 0.42 |
| ▸ | ENPP2 | Q13822 | 1/20 | 0.41 |
| ▸ | POLB | P06746 | 1/20 | 0.41 |
| ▸ | GAA | P10253 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29993703 | 1.00 | CA1 (0.55) | CA1CA2CA7CA9CA12 | |
| Lithium SCHEMBL3800859 | 0.98 | CA1 (0.52) | CA1CA2CA7CA9CA12 | |
| SCHEMBL3800856 | 0.98 | CA1 (0.52) | CA1CA2CA7CA9CA12 | |
| SCHEMBL12821701 | 0.94 | CA1 (0.48) | CA1CA2CA7CA9CA12 | |
| Phenylacetylene SCHEMBL28207279 | 0.90 | CA1 (0.44) | CA1CA2CA7CA9CA12 | |
| SCHEMBL20435262 | 0.83 | APP (0.47) | CA1CA2CA7CA9CA12 | |
| SCHEMBL13726543 | 0.80 | CA1 (0.42) | CA1CA2CA7CA9CA12 | |
| SCHEMBL30174376 | 0.80 | SMN1; SMN2 (0.45) | CA1CA2CA7CA9CA12 | |
| SCHEMBL6196015 | 0.80 | SMN1; SMN2 (0.45) | CA1CA2CA7CA9CA12 | |
| SCHEMBL30022461 | 0.80 | CA1 (0.60) | CA1CA2CA7CA9CA12 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 964 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-122059955-A | Imidazo pyridone compound, photocatalysis continuous synthesis method and application thereof | 南京工业大学 | 2026-05-19 | — | — | CN | claimed |
| CN-118388945-B | High-molecular light-weight automobile mask and production process thereof | 山东金光复合材料股份有限公司 | 2024-12-17 | — | — | CN | claimed |
| CN-115872993-B | Method for continuously synthesizing piperidone by photoinduction | 南京工业大学 | 2024-12-10 | — | — | CN | claimed |
| CN-118930570-A | Copper complex containing ortho-carborane Schiff base ligand and preparation method and application thereof | 上海应用技术大学 | 2024-11-12 | — | — | CN | claimed |
| CN-118515716-A | NNN-pyridine-quinoline cobalt complex, preparation method and catalytic alkyne hydrosilylation reaction | 石河子大学 | 2024-08-20 | — | — | CN | claimed |
| CN-118420615-A | Method for synthesizing pyridoquinazolinone compound by photo-induced organic catalysis alkyne difunctional cyclization | 南京工业大学 | 2024-08-02 | — | — | CN | claimed |
| CN-118388945-A | High-molecular light-weight automobile mask and production process thereof | 山东金光复合材料股份有限公司 | 2024-07-26 | — | — | CN | claimed |
| CN-117886829-A | Pyridoisocoumarin compound and preparation method and application thereof | 河北中烟工业有限责任公司 | 2024-04-16 | — | — | CN | claimed |
| US-11814462-B2 | Functionalized cyclic polymers and methods of preparing same | UNIVERSITY OF FLORIDA RESEARCH FOUNDATION, INC. (US) | 2023-11-14 | — | — | US | claimed |
| EP-3688124-B1 | ESTER COMPOUNDS, LUBRICATING OIL COMPOSITIONS CONTAINING SAME AND PROCESSES FOR MAKING SAME | EXXONMOBIL CHEMICAL PATENTS INC (US) | 2023-10-25 | — | — | EP | claimed |
| US-20030178667-A1 | Memory device | CYPRESS SEMICONDUCTOR CORPORATION | 2003-09-25 | — | — | US | claimed |
| US-20030155602-A1 | Memory device | COATUE CORPORATION | 2003-08-21 | — | — | US | claimed |
| US-20020049213-A1 | Isoxazoles and oxadiazoles as anti-inflammatory inhibitors of IL-8 | ORTHO-MCNEIL PHARMACEUTICAL, INC. | 2002-04-25 | — | — | US | claimed |
| EP-0690855-B1 | BENZOPYRANES AS POTASSIUM CHANNEL OPENERS | PFIZER LTD (GB) | 1996-12-18 | — | — | EP | claimed |
| EP-0393781-B1 | Dopamine pro-drug | ZAMBON SPA (IT) | 1995-02-08 | — | — | EP | claimed |
| EP-0171209-B1 | ACETYLENIC PHENOXYPROPANOL DERIVATIVES AND PHARMACEUTICAL COMPOSITIONS FOR THE TREATMENT OF HYPERTENSION | McNeilab, Inc. (US) | 1989-03-01 | — | — | EP | claimed |
| EP-0171209-A1 | Acetylenic phenoxypropanol derivatives and pharmaceutical compositions for the treatment of hypertension | McNeilab, Inc. (US) | 1986-02-12 | — | — | EP | claimed |
| EP-0032548-B1 | PROCESS FOR PREPARING ARYL AND HETEROARYL HEXADIENOIC ACIDS | Montedison S.p.A. (IT) | 1983-06-22 | — | — | EP | claimed |
| US-4355168-A | Process for preparing aryl- or heteroarylhexadienoic acids | MONTEDISON S.P.A. (IT) | 1982-10-19 | — | — | US | claimed |
| EP-0032548-A1 | Process for preparing aryl and heteroaryl hexadienoic acids | Montedison S.p.A. (IT) | 1981-07-29 | — | — | EP | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20020049213-A1 | Isoxazoles and oxadiazoles as anti-inflammatory inhibitors of IL-8 | CXCL8, IL18, IL1B | CA1 2178/4885CA2 1667/4885CA7 923/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.